Why the study?
Can fetal magnetocardiography (FMCG) accurately diagnose fetal arrhythmias and assess autonomic nervous system activity?
Can fetal magnetocardiography (FMCG) accurately diagnose fetal arrhythmias and assess autonomic nervous system activity?
Fetal magnetocardiography is a useful noninvasive tool for the prenatal diagnosis of complex fetal arrhythmias like long QT syndrome and for assessing fetal autonomic nervous system development.
Answers are grounded in this paper and cite their sources.
FMCG may aid prenatal arrhythmia assessment; leaves open the need for prospective validation before clinical adoption.
Magnetocardiography (MCG) is a technique that enables the noncontact, noninvasive measurement of electrocardiographic phenomena, and fetal magnetocardiography (FMCG) is extremely useful for the analysis of fetal electrocardiographic phenomena. We have used FMCG for the diagnosis and treatment of a range of fetal arrhythmias, and to perform comparative studies of autonomic nervous system activity in fetuses with normal growth and those with fetal growth restriction by analyzing fetal heart rate variability. In terms of fetal arrhythmias, fatal long QT syndrome was accurately diagnosed prenatally using FMCG, and pregnancy was maintained until delivery at 37 weeks gestation. With regard to fetal autonomic nervous system activity, there was a pronounced increase in sympathetic nervous activity among fetuses with normal growth in the second half of pregnancy.
No takes yet. Share an insight, caveat, or question.
Akimune Fukushima (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: